Coagulation factor XIII A chain

F13A1
Available structures
PDB	Ortholog search: PDBe RCSB
List of PDB id codes
	1EVU, 1EX0, 1F13, 1FIE, 1GGT, 1GGU, 1GGY, 1QRK, 4KTY Contents Function ; Interactions ; References ; Further reading ;
Identifiers
Aliases	F13A1 , F13A, coagulation factor XIII A chain
External IDs	OMIM: 134570 MGI: 1921395 HomoloGene: 20077 GeneCards: F13A1
Gene location (Human)
Chr.	Chromosome 6 (human)
End	6,321,013 bp
Gene location (Mouse)
Chr.	Chromosome 13 (mouse)
End	37,234,220 bp
RNA expression pattern
	Top expressed in
	monocyte; ; pericardium; ; placenta; ; synovial joint; ; right coronary artery; ; gastric mucosa; ; gallbladder; ; right ventricle; ; tibia; ; appendix;
	Top expressed in
	ankle; ; intercostal muscle; ; belly cord; ; dermis; ; trachea; ; blood; ; skin of back; ; interventricular septum; ; white adipose tissue; ; skin of abdomen;
	More reference expression data
	More reference expression data
Gene ontology
Molecular function	protein-glutamine gamma-glutamyltransferase activity ; acyltransferase activity ; metal ion binding ; transferase activity ;
Cellular component	cytoplasm ; platelet alpha granule lumen ; blood microparticle ; extracellular region ; collagen-containing extracellular matrix ;
Biological process	peptide cross-linking ; blood coagulation, fibrin clot formation ; platelet degranulation ; hemostasis ; blood coagulation ; cytokine-mediated signaling pathway ;
	Sources:Amigo / QuickGO
Orthologs
	2162
	74145
	ENSG00000124491
	ENSMUSG00000039109
	P00488
	Q8BH61
	NM_000129
	NM_001166391 ; NM_028784
	NP_000120
	NP_001159863 ; NP_083060
	Wikidata
View/Edit Human	View/Edit Mouse

Last updated April 26, 2024

Coagulation factor XIII A chain, (FXIIIa) is a protein that in humans is encoded by the F13A1 gene.

Function

This gene encodes the coagulation factor XIII A subunit. Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is composed of just 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. It also crosslinks alpha-2-plasmin inhibitor, or fibronectin, to the alpha chains of fibrin. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits; and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.^[5]

Interactions

Coagulation factor XIII A chain has been shown to interact with coagulation factor XIII B chain.^[6]^[7]

Related Research Articles

Coagulation, also known as clotting, is the process by which blood changes from a liquid to a gel, forming a blood clot. It potentially results in hemostasis, the cessation of blood loss from a damaged vessel, followed by repair. The mechanism of coagulation involves activation, adhesion and aggregation of platelets, as well as deposition and maturation of fibrin.

<span class="mw-page-title-main">Thrombin</span> Enzyme involved in blood coagulation in humans

Thrombin is a serine protease, an enzyme that, in humans, is encoded by the F2 gene.

Antithrombin (AT) is a small glycoprotein that inactivates several enzymes of the coagulation system. It is a 464-amino-acid protein produced by the liver. It contains three disulfide bonds and a total of four possible glycosylation sites. α-Antithrombin is the dominant form of antithrombin found in blood plasma and has an oligosaccharide occupying each of its four glycosylation sites. A single glycosylation site remains consistently un-occupied in the minor form of antithrombin, β-antithrombin. Its activity is increased manyfold by the anticoagulant drug heparin, which enhances the binding of antithrombin to factor IIa (thrombin) and factor Xa.

Factor XIII or fibrin stabilizing factor is a zymogen found in blood of humans and some other animals. It is activated by thrombin to factor XIIIa. Factor XIIIa is an enzyme of the blood coagulation system that crosslinks fibrin. Deficiency of XIII worsens clot stability and increases bleeding tendency.

Protein S is a vitamin K-dependent plasma glycoprotein synthesized in the liver. In the circulation, Protein S exists in two forms: a free form and a complex form bound to complement protein C4b-binding protein (C4BP). In humans, protein S is encoded by the PROS1 gene. Protein S plays a role in coagulation.

Factor X, also known by the eponym Stuart–Prower factor, is an enzyme of the coagulation cascade. It is a serine endopeptidase. Factor X is synthesized in the liver and requires vitamin K for its synthesis.

Factor XI or plasma thromboplastin antecedent is the zymogen form of factor XIa, one of the enzymes of the coagulation cascade. Like many other coagulation factors, it is a serine protease. In humans, Factor XI is encoded by the F11 gene.

The prothrombinase enzyme complex consists of factor Xa (a serine protease) and factor Va (a protein cofactor). The complex assembles on negatively charged phospholipid membranes in the presence of calcium ions. The prothrombinase complex catalyzes the conversion of prothrombin (factor II), an inactive zymogen, to thrombin (factor IIa), an active serine protease. The activation of thrombin is a critical reaction in the coagulation cascade, which functions to regulate hemostasis in the body. To produce thrombin, the prothrombinase complex cleaves two peptide bonds in prothrombin, one after Arg²⁷¹ and the other after Arg³²⁰. Although it has been shown that factor Xa can activate prothrombin when unassociated with the prothrombinase complex, the rate of thrombin formation is severely decreased under such circumstances. The prothrombinase complex can catalyze the activation of prothrombin at a rate 3 x 10⁵-fold faster than can factor Xa alone. Thus, the prothrombinase complex is required for the efficient production of activated thrombin and also for adequate hemostasis.

Plasma kallikrein is an enzyme that catalyses the following chemical reaction:

Heparin cofactor II (HCII), a protein encoded by the SERPIND1 gene, is a coagulation factor that inhibits IIa, and is a cofactor for heparin and dermatan sulfate.

β₂-glycoprotein 1, also known as beta-2 glycoprotein 1 and Apolipoprotein H (Apo-H), is a 38 kDa multifunctional plasma protein that in humans is encoded by the APOH gene. One of its functions is to bind cardiolipin. When bound, the structure of cardiolipin and β₂-GP1 both undergo large changes in structure. Within the structure of Apo-H is a stretch of positively charged amino acids, Lys-Asn-Lys-Glu-Lys-Lys, are involved in phospholipid binding.

Fibrinogen gamma chain, also known as fibrinogen gamma gene (FGG), is a human gene found on chromosome 3.

An Error has occurred retrieving Wikidata item for infobox Coagulation factor XIII B chain is a protein that in humans is encoded by the F13B gene.

Protease activated receptor 3 (PAR-3) also known as coagulation factor II receptor-like 2 (F2RL2) and thrombin receptor-like 2, is a protein that in humans is encoded by the F2RL2 gene.

Fibrinogen beta chain, also known as FGB, is a gene found in humans and most other vertebrates with a similar system of blood coagulation.

Protease-activated receptor 4 (PAR-4), also known as coagulation factor II (thrombin) receptor-like 3, is a protein that in humans is encoded by the F2RL3 gene.

Carboxypeptidase B2 (CPB2), also known as carboxypeptidase U (CPU), plasma carboxypeptidase B (pCPB) or thrombin-activatable fibrinolysis inhibitor (TAFI), is an enzyme that, in humans, is encoded by the gene CPB2.

Glycoprotein V (platelet) (GP5) also known as CD42d (Cluster of Differentiation 42d), is a human gene.

Fibrin glue is a surgical formulation used to create a fibrin clot for hemostasis, cartilage repair surgeries or wound healing. It contains separately packaged human fibrinogen and human thrombin.

Blood clotting tests are the tests used for diagnostics of the hemostasis system. Coagulometer is the medical laboratory analyzer used for testing of the hemostasis system. Modern coagulometers realize different methods of activation and observation of development of blood clots in blood or in blood plasma.

References

1 2 3 GRCh38: Ensembl release 89: ENSG00000124491 – Ensembl, May 2017
1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000039109 – Ensembl, May 2017
↑ "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑ "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.
↑ "Entrez Gene: F13A1 coagulation factor XIII, A1 polypeptide".
↑ Carrell NA, Erickson HP, McDonagh J (Jan 1989). "Electron microscopy and hydrodynamic properties of factor XIII subunits". J. Biol. Chem. 264 (1): 551–6. doi: 10.1016/S0021-9258(17)31294-2 . PMID 2491853.
↑ Achyuthan KE, Rowland TC, Birckbichler PJ, Lee KN, Bishop PD, Achyuthan AM (Sep 1996). "Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin". Mol. Cell. Biochem. 162 (1): 43–9. doi:10.1007/bf00250994. PMID 8905624. S2CID 23583301.

Adány R (1997). "Intracellular factor XIII: cellular distribution of factor XIII subunit a in humans". Semin. Thromb. Hemost. 22 (5): 399–408. doi:10.1055/s-2007-999038. PMID 8989823. S2CID 22915173.
Adány R, Bárdos H (2003). "Factor XIII subunit A as an intracellular transglutaminase". Cell. Mol. Life Sci. 60 (6): 1049–60. doi:10.1007/s00018-003-2178-9. PMID 12861374. S2CID 7831538.
Bereczky Z, Katona E, Muszbek L (2005). "Fibrin stabilization (factor XIII), fibrin structure and thrombosis". Pathophysiol. Haemost. Thromb. 33 (5–6): 430–7. doi:10.1159/000083841. PMID 15692256. S2CID 12156307.
Board P, Coggan M, Miloszewski K (1992). "Identification of a point mutation in factor XIII A subunit deficiency". Blood. 80 (4): 937–41. doi: 10.1182/blood.V80.4.937.937 . PMID 1353995.
Kamura T, Okamura T, Murakawa M, Tsuda H, Teshima T, Shibuya T, Harada M, Niho Y (1992). "Deficiency of coagulation factor XIII A subunit caused by the dinucleotide deletion at the 5' end of exon III". J. Clin. Invest. 90 (2): 315–9. doi:10.1172/JCI115864. PMC 443104 . PMID 1644910.
Harsfalvi J, Fesus L, Tarcsa E, Laczko J, Loewy AG (1991). "The presence of a covalently cross-linked matrix in human platelets". Biochim. Biophys. Acta. 1073 (2): 268–74. doi:10.1016/0304-4165(91)90131-Y. PMID 2009280.
Bishop PD, Teller DC, Smith RA, Lasser GW, Gilbert T, Seale RL (1990). "Expression, purification, and characterization of human factor XIII in Saccharomyces cerevisiae". Biochemistry. 29 (7): 1861–9. doi:10.1021/bi00459a028. PMID 2184890.
Hilgenfeld R, Liesum A, Storm R, Metzner HJ, Karges HE (1990). "Crystallization of blood coagulation factor XIII by an automated procedure". FEBS Lett. 265 (1–2): 110–2. doi: 10.1016/0014-5793(90)80896-Q . PMID 2365049. S2CID 23295980.
Carrell NA, Erickson HP, McDonagh J (1989). "Electron microscopy and hydrodynamic properties of factor XIII subunits". J. Biol. Chem. 264 (1): 551–6. doi: 10.1016/S0021-9258(17)31294-2 . PMID 2491853.
Takahashi N, Takahashi Y, Putnam FW (1986). "Primary structure of blood coagulation factor XIIIa (fibrinoligase, transglutaminase) from human placenta". Proc. Natl. Acad. Sci. U.S.A. 83 (21): 8019–23. Bibcode:1986PNAS...83.8019T. doi: 10.1073/pnas.83.21.8019 . PMC 386858 . PMID 2877456.
Grundmann U, Amann E, Zettlmeissl G, Küpper HA (1986). "Characterization of cDNA coding for human factor XIIIa". Proc. Natl. Acad. Sci. U.S.A. 83 (21): 8024–8. Bibcode:1986PNAS...83.8024G. doi: 10.1073/pnas.83.21.8024 . PMC 386859 . PMID 2877457.
Ichinose A, Davie EW (1988). "Characterization of the gene for the a subunit of human factor XIII (plasma transglutaminase), a blood coagulation factor". Proc. Natl. Acad. Sci. U.S.A. 85 (16): 5829–33. Bibcode:1988PNAS...85.5829I. doi: 10.1073/pnas.85.16.5829 . PMC 281858 . PMID 2901091.
Board PG, Webb GC, McKee J, Ichinose A (1988). "Localization of the coagulation factor XIII A subunit gene (F13A) to chromosome bands 6p24----p25". Cytogenet. Cell Genet. 48 (1): 25–7. doi:10.1159/000132580. PMID 2903011.
Ichinose A, Hendrickson LE, Fujikawa K, Davie EW (1987). "Amino acid sequence of the a subunit of human factor XIII". Biochemistry. 25 (22): 6900–6. doi:10.1021/bi00370a025. PMID 3026437.
Takagi T, Doolittle RF (1974). "Amino acid sequence studies on factor XIII and the peptide released during its activation by thrombin". Biochemistry. 13 (4): 750–6. doi:10.1021/bi00701a018. PMID 4811064.
Yee VC, Pedersen LC, Bishop PD, Stenkamp RE, Teller DC (1995). "Structural evidence that the activation peptide is not released upon thrombin cleavage of factor XIII". Thromb. Res. 78 (5): 389–97. doi:10.1016/0049-3848(95)00072-Y. PMID 7660355.
Coggan M, Baker R, Miloszewski K, Woodfield G, Board P (1995). "Mutations causing coagulation factor XIII subunit A deficiency: characterization of the mutant proteins after expression in yeast". Blood. 85 (9): 2455–60. doi: 10.1182/blood.V85.9.2455.bloodjournal8592455 . PMID 7727776.
Kaczmarek E, Liu Y, Berse B, Chen CS, McDonagh J (1995). "Biosynthesis of plasma factor XIII: evidence for transcription and translation in hepatoma cells". Biochim. Biophys. Acta. 1247 (1): 127–34. doi:10.1016/0167-4838(94)00167-f. PMID 7873582.
Yee VC, Pedersen LC, Le Trong I, Bishop PD, Stenkamp RE, Teller DC (1994). "Three-dimensional structure of a transglutaminase: human blood coagulation factor XIII". Proc. Natl. Acad. Sci. U.S.A. 91 (15): 7296–300. Bibcode:1994PNAS...91.7296Y. doi: 10.1073/pnas.91.15.7296 . PMC 44386 . PMID 7913750.
Suzuki K, Iwata M, Ito S, Matsui K, Uchida A, Mizoi Y (1994). "Molecular basis for subtypic differences of the "a" subunit of coagulation factor XIII with description of the genesis of the subtypes". Hum. Genet. 94 (2): 129–35. doi:10.1007/bf00202857. PMID 7913909. S2CID 20800219.

This article on a gene on human chromosome 6 is a stub. You can help Wikipedia by expanding it.

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.

[refGRCh38Ensembl-1] 1 2 3 GRCh38: Ensembl release 89: ENSG00000124491 – Ensembl, May 2017

[refGRCm38Ensembl-2] 1 2 3 GRCm38: Ensembl release 89: ENSMUSG00000039109 – Ensembl, May 2017

[3] "Human PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[4] "Mouse PubMed Reference:". National Center for Biotechnology Information, U.S. National Library of Medicine.

[5] "Entrez Gene: F13A1 coagulation factor XIII, A1 polypeptide".

[pmid2491853-6] Carrell NA, Erickson HP, McDonagh J (Jan 1989). "Electron microscopy and hydrodynamic properties of factor XIII subunits". J. Biol. Chem. 264 (1): 551–6. doi: 10.1016/S0021-9258(17)31294-2 . PMID 2491853.

[pmid8905624-7] Achyuthan KE, Rowland TC, Birckbichler PJ, Lee KN, Bishop PD, Achyuthan AM (Sep 1996). "Hierarchies in the binding of human factor XIII, factor XIIIa, and endothelial cell transglutaminase to human plasma fibrinogen, fibrin, and fibronectin". Mol. Cell. Biochem. 162 (1): 43–9. doi:10.1007/bf00250994. PMID 8905624. S2CID 23583301.

[1]

[2]

[3]

[4]

[5]

[6]

[7]

Coagulation factor XIII A chain

Contents

Function

Interactions

Related Research Articles

References

Further reading